LINTUZUMAB
UNII V00Y10W60W

Substance Identification & Data

This profile provides standardized clinical and technical data for Lintuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V00Y10W60W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 166089-32-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V00Y10W60W

CAS Registry Number

166089-32-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LINTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C1716

National Cancer Institute reference terminology for clinical and research data.

INN ID

7580

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lintuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LINTUZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER

LINTUZUMAB [INN]

LINTUZUMAB [WHO-DD]